Although AML patients with IDH1 mutations and AML patients with IDH2 mutations show a significant overlap in the differentially expressed genes, in a meta-analysis including 12,747 patients, it was reported that IDH1 mutation was associated with inferior OS and EFS while IDH2 mutation was associated with favorable OS [210]. This evidence concerns the gene IDH1 and acute myeloid leukemia.